THE FUND FOR BLOOD AND CANCER RESE… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1980

Legal Domicile

Principal Officer

DR MARK PASMANTIER

Phone

2125175900

Tax Period

2023-01-01 to 2023-12-31

THE FUND FOR BLOOD AND CANCER RESEARCHINC, founded in 1980, is a micro nonprofit that reported $59K in total revenue in fiscal year 2023. Revenue fell 40% from the prior year — a significant decline worth monitoring. Expenses of $283K exceeded revenue, resulting in a 377% operating deficit.

Mission

FUNDING FOR CANCER RESEARCH, INCLUDING LUNG CANCER, LYMPHOMA, MYELONA AND UROLOGIC MALIGNANCIES.

Program Service Accomplishments

Program 1

Expenses: $262,616 Revenue: $14,512

EARLY LUNG CANCER DETECTION PROJECT, UTILIZING SCREENING TO HELP DETECT CANCER AT THE EARLIEST STAGES.PROJECT GRANTS FOR LYMPHOMA AND MYELOMA RESEARCH AS WELL AS UROLOGIC MALIGNANCIES

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $14,512

Program Service Revenue $0

Investment Income $44,921

Other Revenue $0

TOTAL REVENUE $59,433

Expense Breakdown

Grants Paid $257,482

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $262,616

Other Expenses $25,868

TOTAL EXPENSES $283,350

Year-over-Year Comparison

	2023	2022	Change
Revenue	$59,433	$99,757	-0.4%
Expenses	$283,350	$47,586	+5.0%
Net Income	$-223,917	$52,171	-5.3%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MORTON COLEMAN MD	CO-CHAIRMAN	5.00	Officer Director	$0	$0	$0
MARK PASMANTIER MD	CO-CHAIRMAN	5.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$59,433	$283,350	$2,026,458	$-223,917
2022	$99,757	$47,586	$2,128,056	$52,171
2021	$112,918	$35,191	$2,305,853	$77,727
2020	$83,256	$36,706	$2,162,190	$46,550

THE FUND FOR BLOOD AND CANCER RESEARCHINC